药剂师驱动的降低处方,以减少老兵痴呆症的抗胆固醇负担
Bailey Deglow1, Holly Embree1, Jiahui Chen1
1Veterans Affairs Louisville Healthcare System, Kentucky.
概括
药剂师可以减少退伍军人患有痴呆症的抗胆固醇药物负担. 这项质量改进项目强调了药剂师主导的使用人口健康工具和跨学科合作来减少处方,以获得更安全的患者护理.
科学领域:
- 老年人药房 老年人药房
- 药物经济学 药物经济学
- 改善临床质量 改善临床质量
背景情况:
- 抗胆固醇药物对痴呆症患者构成风险.
- 大约35%患有痴呆症的退伍军人具有高抗胆固醇负担.
- 美国老年病学协会建议不要在这个人群中使用这些药物.
研究的目的:
- 检查药剂师在减轻痴呆症退伍军人的抗胆固醇负担方面的作用.
- 实施一个质量改进项目,重点是降低抗胆固醇药物的处方.
主要方法:
- 利用VIONE的降低处方仪表板来识别服用酒标准中列出的抗胆固醇药物的患者.
- 由药剂师领导的电子健康记录药物审查.
- 与处方医生和初级保健从业者合作进行风险益处评估和减缓处方.
主要成果:
- 药剂师成功地发现并促进了不适当的抗胆固醇药物的处方.
- 人口健康管理工具有助于识别具有高抗胆固醇负担的患者.
- 跨学科的合作是项目的成功的关键.
结论:
- 药剂师在减轻退伍军人痴呆症的抗胆固醇负担方面发挥着至关重要的作用.
- 人口健康管理工具和跨学科的团队合作增强了药剂师领导的减处方工作.
- 为更安全的替代品提供以证据为基础的建议支持抗胆固醇抑郁药的处方.
更多相关视频
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
9.9K
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.6K
相关概念视频
Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265
Drug Therapy
107
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
107
Antidepressant Drugs: MAOIs and Other Agents
380
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
380
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
856
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
856
Parkinson's Disease: Treatment
391
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
391
Anticholinesterase Agents: Poisoning and Treatment
1.0K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.0K
